Development of cyclic peptides that can be administered orally to inhibit disease targets
Nat Chem Biol
.
2024 May;20(5):551-552.
doi: 10.1038/s41589-023-01505-0.
PMID:
38155305
DOI:
10.1038/s41589-023-01505-0
No abstract available
MeSH terms
Administration, Oral
Animals
Drug Development / methods
Humans
Peptides, Cyclic* / administration & dosage
Peptides, Cyclic* / chemistry
Peptides, Cyclic* / pharmacology
Substances
Peptides, Cyclic